Skip to content

Main Navigation

Omniabio
  • Home
  • CDMO Services
    • Services overview
    • Platform Leadership
    • Extensive Expertise
    • Case Studies
  • Manufacturing Infrastructure
    • Infrastructure Overview
    • Facilities by project stage
  • News
    • News Releases
    • OmniaBio in the News
    • Recent Highlights
  • Events
  • Careers
  • Contact Us
  • Mailing list

News Releases

March 14, 2023
Catamaran Bio selects OmniaBio as partner to develop and manufacture allogeneic CAR-NK cell therapies
January 24, 2023
OmniaBio expands manufacturing footprint with second Hamilton location
November 29, 2022
Avectas, CCRM and OmniaBio Expand their Collaboration to Accelerate the Manufacture of Edited iPSCs Using SOLUPORE® Technology.
November 7, 2022
Resolution Therapeutics and CCRM sign collaboration agreement, with work to be executed at OmniaBio.
October 6, 2022
OmniaBio celebrates the beginning of construction.
September 20, 2022
NGen Supports Commercial Scale Manufacturing of Cell and Gene Therapies in Canada.
May 31, 2022
OmniaBio Inc. announces private investor.
March 31, 2022
Funding from Ontario Government for OmniaBio.
March 31, 2022
Invest Ontario Supports New Biomanufacturing Facility in Hamilton.
Contact us to learn more about how we can support your needs at cdmo@omniabio.com.
© 2023 OmniaBio Inc.
Privacy Policy